These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16395998)

  • 1. Superior safety in noninferiority trials.
    Bristol DR
    Biom J; 2005 Feb; 47(1):75-81; discussion 99-107. PubMed ID: 16395998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic equivalence--clinical issues and statistical methodology in noninferiority trials.
    Munk A; Trampisch HJ
    Biom J; 2005 Feb; 47(1):7-9; discussion 99-107. PubMed ID: 16395992
    [No Abstract]   [Full Text] [Related]  

  • 3. Methods for assessing noninferiority with censored data.
    Freitag G
    Biom J; 2005 Feb; 47(1):88-98; discussion 99-107. PubMed ID: 16396000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Testing superiority and non-inferiority hypotheses in active controlled clinical trials".
    Röhmel J; Hauschke D
    Biom J; 2006 Feb; 48(1):174-5; author reply 176. PubMed ID: 16544822
    [No Abstract]   [Full Text] [Related]  

  • 5. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems with existing procedures to calculate exact unconditional P-values for non-inferiority/superiority and confidence intervals for two binomials and how to resolve them.
    Röhmel J
    Biom J; 2005 Feb; 47(1):37-47; discussion 99-107. PubMed ID: 16395995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes.
    Wellek S
    Biom J; 2005 Feb; 47(1):48-61; discussion 99-107. PubMed ID: 16395996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
    Tsong Y; Zhang JJ
    Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of delta: requirements and reality--results of a systematic review.
    Lange S; Freitag G
    Biom J; 2005 Feb; 47(1):12-27; discussion 99-107. PubMed ID: 16395993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biostatistical assessment of mutagenicity studies by including the positive control.
    Hauschke D; Slacik-Erben R; Hensen S; Kaufmann R
    Biom J; 2005 Feb; 47(1):82-7; discussion 99-107. PubMed ID: 16395999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating equivalence and noninferiority trials.
    Dasgupta A; Lawson KA; Wilson JP
    Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.
    Gomberg-Maitland M; Frison L; Halperin JL
    Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation and inference in noninferiority randomized controlled trials in drug research.
    Wangge G; Klungel OH; Roes KC; de Boer A; Hoes AW; Knol MJ
    Clin Pharmacol Ther; 2010 Sep; 88(3):420-3. PubMed ID: 20668448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.
    Hong J; Tung A; Kinkade A; Tejani AM
    J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple comparisons and multiple contrasts in randomized dose-response trials--confidence interval oriented approaches.
    Hothorn LA
    J Biopharm Stat; 2006; 16(5):711-31. PubMed ID: 17037267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and statistical issues in therapeutic equivalence trials.
    Garbe E; Röhmel J; Gundert-Remy U
    Eur J Clin Pharmacol; 1993; 45(1):1-7. PubMed ID: 8405023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What differences are detected by superiority trials or ruled out by noninferiority trials? A cross-sectional study on a random sample of two-hundred two-arms parallel group randomized clinical trials.
    Gayet-Ageron A; Agoritsas T; Combescure C; Bagamery K; Courvoisier DS; Perneger TV
    BMC Med Res Methodol; 2010 Oct; 10():93. PubMed ID: 20950464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.
    Soonawala D; Middelburg RA; Egger M; Vandenbroucke JP; Dekkers OM
    Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.